Cannabis in the Americas: It’s time to talk about marijuana policy

It is within our power to design a regulatory framework that is mutually beneficial to corporations and small-scale actors
The Globe and Mail (Canada)
Tuesday, September 3, 2019

colombia cannabis medicinal invernaderoThere is now a unique moment to build a coherent regulatory framework that would prevent the growing cannabis market from being concentrated in the hands of large for-profit conglomerates, beholden to purely commercial interests, which might well introduce new harms just as those created by prohibition are being mitigated. It is particularly important do so before big actors such as the United States follow and legalize medical cannabis at the federal level. There is first a pressing need to knock down the considerable market barriers that exist for small-scale farmers from traditional producer countries in low- and middle-income countries. These actors have often been those most affected by the so-called “war on drugs”, which has fostered discrimination, poverty, violence, and fear.